SFDA To Issue Regulation On Technology Transfer Registrations
This article was originally published in PharmAsia News
Executive Summary
China's State FDA has finalized its policy on technology transfer registration for drugs, which it will issue this month. The regulation will encourage adoption and implementation of mature or advanced production technology, while reducing the number of approvals for new generics. In addition, approval and supervision of transferred drugs will be tightened and will forbid transfer application of high-risk drugs, suspend transfer of drugs with newly detected safety risks and reject transfer of drugs with risks found during technology reviews. (Click here for more - Chinese Language)